Cargando…
Predictors of COVID-19 Vaccine Hesitancy: Socio-Demographics, Co-Morbidity, and Past Experience of Racial Discrimination
The goal of this study is to explore predictors of COVID-19 vaccine hesitancy, including socio-demographic factors, comorbidity, risk perception, and experience of discrimination, in a sample of the U.S. population. We used a cross-sectional online survey study design, implemented between 13–23 Dece...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310049/ https://www.ncbi.nlm.nih.gov/pubmed/34358184 http://dx.doi.org/10.3390/vaccines9070767 |
_version_ | 1783728667018395648 |
---|---|
author | Savoia, Elena Piltch-Loeb, Rachael Goldberg, Beth Miller-Idriss, Cynthia Hughes, Brian Montrond, Alberto Kayyem, Juliette Testa, Marcia A. |
author_facet | Savoia, Elena Piltch-Loeb, Rachael Goldberg, Beth Miller-Idriss, Cynthia Hughes, Brian Montrond, Alberto Kayyem, Juliette Testa, Marcia A. |
author_sort | Savoia, Elena |
collection | PubMed |
description | The goal of this study is to explore predictors of COVID-19 vaccine hesitancy, including socio-demographic factors, comorbidity, risk perception, and experience of discrimination, in a sample of the U.S. population. We used a cross-sectional online survey study design, implemented between 13–23 December 2020. The survey was limited to respondents residing in the USA, belonging to priority groups for vaccine distribution. Responses were received from 2650 individuals (response rate 84%) from all 50 states and Puerto Rico, American Samoa, and Guam. The five most represented states were California (13%), New York (10%), Texas (7%), Florida (6%), and Pennsylvania (4%). The majority of respondents were in the age category 25–44 years (66%), male (53%), and working in the healthcare sector (61%). Most were White and non-Hispanic (66%), followed by Black and non-Hispanic (14%) and Hispanic (8%) respondents. Experience with racial discrimination was a predictor of vaccine hesitancy. Those reporting racial discrimination had 21% increased odds of being at a higher level of hesitancy compared to those who did not report such experience (OR = 1.21, 95% C.I. 1.01–1.45). Communication and logistical aspects during the COVID-19 vaccination campaign need to be sensitive to individuals’ past-experience of racial discrimination in order to increase vaccine coverage. |
format | Online Article Text |
id | pubmed-8310049 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83100492021-07-25 Predictors of COVID-19 Vaccine Hesitancy: Socio-Demographics, Co-Morbidity, and Past Experience of Racial Discrimination Savoia, Elena Piltch-Loeb, Rachael Goldberg, Beth Miller-Idriss, Cynthia Hughes, Brian Montrond, Alberto Kayyem, Juliette Testa, Marcia A. Vaccines (Basel) Article The goal of this study is to explore predictors of COVID-19 vaccine hesitancy, including socio-demographic factors, comorbidity, risk perception, and experience of discrimination, in a sample of the U.S. population. We used a cross-sectional online survey study design, implemented between 13–23 December 2020. The survey was limited to respondents residing in the USA, belonging to priority groups for vaccine distribution. Responses were received from 2650 individuals (response rate 84%) from all 50 states and Puerto Rico, American Samoa, and Guam. The five most represented states were California (13%), New York (10%), Texas (7%), Florida (6%), and Pennsylvania (4%). The majority of respondents were in the age category 25–44 years (66%), male (53%), and working in the healthcare sector (61%). Most were White and non-Hispanic (66%), followed by Black and non-Hispanic (14%) and Hispanic (8%) respondents. Experience with racial discrimination was a predictor of vaccine hesitancy. Those reporting racial discrimination had 21% increased odds of being at a higher level of hesitancy compared to those who did not report such experience (OR = 1.21, 95% C.I. 1.01–1.45). Communication and logistical aspects during the COVID-19 vaccination campaign need to be sensitive to individuals’ past-experience of racial discrimination in order to increase vaccine coverage. MDPI 2021-07-09 /pmc/articles/PMC8310049/ /pubmed/34358184 http://dx.doi.org/10.3390/vaccines9070767 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Savoia, Elena Piltch-Loeb, Rachael Goldberg, Beth Miller-Idriss, Cynthia Hughes, Brian Montrond, Alberto Kayyem, Juliette Testa, Marcia A. Predictors of COVID-19 Vaccine Hesitancy: Socio-Demographics, Co-Morbidity, and Past Experience of Racial Discrimination |
title | Predictors of COVID-19 Vaccine Hesitancy: Socio-Demographics, Co-Morbidity, and Past Experience of Racial Discrimination |
title_full | Predictors of COVID-19 Vaccine Hesitancy: Socio-Demographics, Co-Morbidity, and Past Experience of Racial Discrimination |
title_fullStr | Predictors of COVID-19 Vaccine Hesitancy: Socio-Demographics, Co-Morbidity, and Past Experience of Racial Discrimination |
title_full_unstemmed | Predictors of COVID-19 Vaccine Hesitancy: Socio-Demographics, Co-Morbidity, and Past Experience of Racial Discrimination |
title_short | Predictors of COVID-19 Vaccine Hesitancy: Socio-Demographics, Co-Morbidity, and Past Experience of Racial Discrimination |
title_sort | predictors of covid-19 vaccine hesitancy: socio-demographics, co-morbidity, and past experience of racial discrimination |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310049/ https://www.ncbi.nlm.nih.gov/pubmed/34358184 http://dx.doi.org/10.3390/vaccines9070767 |
work_keys_str_mv | AT savoiaelena predictorsofcovid19vaccinehesitancysociodemographicscomorbidityandpastexperienceofracialdiscrimination AT piltchloebrachael predictorsofcovid19vaccinehesitancysociodemographicscomorbidityandpastexperienceofracialdiscrimination AT goldbergbeth predictorsofcovid19vaccinehesitancysociodemographicscomorbidityandpastexperienceofracialdiscrimination AT milleridrisscynthia predictorsofcovid19vaccinehesitancysociodemographicscomorbidityandpastexperienceofracialdiscrimination AT hughesbrian predictorsofcovid19vaccinehesitancysociodemographicscomorbidityandpastexperienceofracialdiscrimination AT montrondalberto predictorsofcovid19vaccinehesitancysociodemographicscomorbidityandpastexperienceofracialdiscrimination AT kayyemjuliette predictorsofcovid19vaccinehesitancysociodemographicscomorbidityandpastexperienceofracialdiscrimination AT testamarciaa predictorsofcovid19vaccinehesitancysociodemographicscomorbidityandpastexperienceofracialdiscrimination |